Co-Analyst Research

Research Notes & Thematic Analysis

Co-Analyst driven research on thematic trends, public companies and competitive landscapes.

Prologis Q3 2026 Earnings Preview: PLD Results and Guidance

Prologis (PLD) Q3 2026 earnings preview: consensus sees 8.9% revenue growth and strong leasing momentum. Get the latest results and guidance.

TSMC (TSM) Q3 2026 earnings preview: consensus expects $45.8B revenue and 66.5% gross margin. Find out what to watch for in the results.

UnitedHealth (UNH) boosts 2026 EPS outlook and buybacks. Preview Q3 earnings, Medicare Advantage, and OptumHealth trends.

Wells Fargo (WFC) Q3 2026 earnings preview: double-digit loan growth, $22.6B revenue, and guidance updates. Find out what to watch next.

10x Genomics (TXG) shifted to a recurring revenue model, growing to $642.8M in 2025 and narrowing losses. See full financial and product analysis.

AbCellera Biologics (ABCL) pivots to clinical-stage biotech in 2026, advancing its pipeline and securing $110M in new partnerships.

Adaptive Biotechnologies (ADPT) achieved strong 2025 growth, led by MRD diagnostics and improved financials. See full ADPT stock analysis.

Avantor (AVTR) reported $6.55B FY2025 sales and a major net loss after restructuring. Get the latest financial analysis and outlook.

Azenta (AZTA) focuses on life sciences with $593.8M revenue in 2025 and strong cash reserves. Discover key financial trends and outlook.